EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Nanocarrier-Based Drug Delivery Systems Targeting Kidney Diseases

Laura Zucaro, Consiglia Longobardi, Antonio Miele, Antonio Villanova, Yoko Suzumoto

Kidney and Blood Pressure Research · 15.10.2024 · 49 (1) · 884-897

DOI: 10.1159/000541848 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Kidney and Blood Pressure Research, online erschienen am 15.10.2024. Verfasst von Laura Zucaro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biogem, Molecular Biology and Genetics Research Institute, Ariano Irpino, Italy. Hauptthemen laut MEDLINE: Kidney Diseases, Drug Delivery Systems, Nanoparticles, Drug Carriers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: The potential applications of nanotechnology in the medical field have become increasingly recognized in recent years. Nanocarriers have emerged as a versatile tool, offering a wide range of applications due to their unique properties. In addition to the targeted drugs delivery, nanocarriers have also proven to be extremely effective in imaging and diagnostics. Continuous advances in nanotechnology have paved the way for innovative solutions to complex challenges in human health, shaping the future of nanotechnology and its applications. Summary: By exploring different types of nanoparticles, this review delves into the different characteristics that can be tailored to enhance their kidney access. Although the structural complexity of the kidney may prevent nanocarriers passage, optimization of nanocarrier characteristics such as shape, size, charge, and surface modifications may overcome these barriers, allowing for targeted delivery. By harnessing the potential of nanoparticles, researchers aim to develop targeted and efficient therapies that can address various kidney-related disorders. Key Messages: This review highlights the promising advancements in nanotechnology and their potential impact on improving the therapeutic outcomes for several kidney diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney DiseasesDrug Delivery SystemsNanoparticlesDrug CarriersHumansAnimalsNanotechnology

Stichwörter der Autor:innen

GlomeruliKidney diseasesNanomedicineRenal tubulesTargeted drug delivery

Substanzen

Drug Carriers

Autor:innen und Institutionen

  • Biogem, Molecular Biology and Genetics Research Institute, Ariano Irpino, Italy.
  • Department of Mental, Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Institute of Biochemistry and Cell Biology, National Research Council of Italy (CNR), Naples, Italy.

Zitieren

APA

Zucaro, L., Longobardi, C., Miele, A., Villanova, A., & Suzumoto, Y. (2024). Nanocarrier-Based Drug Delivery Systems Targeting Kidney Diseases. Kidney and Blood Pressure Research, 49(1), 884-897. https://doi.org/10.1159/000541848

Vancouver

Zucaro L, Longobardi C, Miele A, Villanova A, Suzumoto Y. Nanocarrier-Based Drug Delivery Systems Targeting Kidney Diseases. Kidney and Blood Pressure Research. 2024;49(1):884-897. doi:10.1159/000541848

BibTeX
@article{Zucaro2024,
  author = {Zucaro, Laura and Longobardi, Consiglia and Miele, Antonio and Villanova, Antonio and Suzumoto, Yoko},
  title = {Nanocarrier-Based Drug Delivery Systems Targeting Kidney Diseases},
  journal = {Kidney and Blood Pressure Research},
  year = {2024},
  volume = {49},
  number = {1},
  pages = {884--897},
  doi = {10.1159/000541848}
}
Kostenlos starten →